Treatment patterns and markers in bladder cancer in Russia
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how bladder cancer is treated and what biological markers are present in patients in Russia. If you join, you may help doctors learn more about which treatments work best based on your tumor type.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You're 18 years or older.
- You have a confirmed diagnosis of urothelial bladder cancer (the most common type).
- Your cancer is non-muscle invasive, muscle invasive, or has spread (metastatic).
- You have a tumor tissue sample (FFPE) that can be tested in a lab.
- You haven't been in any other treatment trials since your diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects your medical information and tissue/biologic samples before bladder surgery. The goal is to better study specific types of bladder cancer, which may help future diagnosis and treatment decisions.
This trial uses special MRI scans and tiny markers placed in the bladder to better plan bladder chemoradiation. The goal is to help target treatment more accurately and improve how well it can be delivered.
This study looks at tumor and blood samples from people with muscle-invasive bladder cancer to find markers that help predict how the disease will progress. It aims to improve personalized treatment for those with this specific stage of bladder cancer.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This study looks for specific DNA changes in bladder cancer tumors using a precise test. It aims to better understand the disease and may help guide future treatment choices.
This study looks at how people with bladder cancer decide to join clinical trials. You may help researchers understand what matters most to patients like you.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.